Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
-
Published:2023-10
Issue:10
Volume:41
Page:1749-1762.e6
-
ISSN:1535-6108
-
Container-title:Cancer Cell
-
language:en
-
Short-container-title:Cancer Cell
Author:
Chen KezhongORCID,
Yang Fan,
Shen Haifeng,
Wang Chenyang,
Li Xi,
Chervova Olga,
Wu Shuailai,
Qiu Fujun,
Peng Di,
Zhu Xin,
Chuai Shannon,
Beck Stephan,
Kanu Nnennaya,
Carbone David,
Zhang Zhihong,
Wang Jun
Subject
Cancer Research,Oncology
Reference32 articles.
1. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J. Natl. Compr. Cancer Netw.,2017
2. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial;Westeel;Lancet Oncol.,2022
3. Liquid biopsies come of age: towards implementation of circulating tumour DNA;Wan;Nat. Rev. Cancer,2017
4. Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study;Parkinson;PLoS Med.,2016
5. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer;Jee;Nat. Med.,2022
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献